Clinical Trial

Study of Letrozole in Recurrent Gliomas

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the ability of letrozole to penetrate the blood brain barrier and concentrate in gliomas.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2017-04-17; most recent amendment 2026-04-13.
Status change: Active, Not Recruiting → Recruiting 2023-12-06
Status change: Recruiting → Active, Not Recruiting 2022-10-03
Status change: Not Yet Recruiting → Recruiting 2017-07-20
Trial Details
NCT Number NCT03122197
Lead Sponsor University of Cincinnati
Conditions Brain Tumor
Enrollment 39 participants
Start Date 2017-05-16
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-16